Proteon Therapeutics Garners $15,183,371 New Financing Round
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6c5db6c2-71b6-4919-930e-2cd613866a3a&Preview=1
Date 8/12/2011
Company Name Proteon Therapeutics
Mailing Address 200 West Street Waltham, MA 02451
Company Description Proteon Therapeutics is a biopharmaceutical company developing PRT-201, a novel human recombinant protein that permanently dilates segments of blood vessels, blocks vasospasm, and reduces the formation of vascular scarring.
Proceeds Purposes Proceeds purposes were not disclosed. Amount may include options, warrants or other rights to acquire other securities. SEC regulatory filing.